Common Contracts
2 similar Master Joint Venture Agreement contracts by Maxygen Inc
EX-2.1 2 dex21.htm MASTER JOINT VENTURE AGREEMENT MASTER JOINT VENTURE AGREEMENT by and between Maxygen, Inc., a Delaware Corporation, Astellas Phama Inc., a Japanese Corporation, and Astellas Bio Inc., a Delaware Corporation Dated as of June 30, 2009...Master Joint Venture Agreement • May 5th, 2020 • Delaware
This Master Joint Venture Agreement (this “Agreement”) is made and entered into as of this 30th day of June, 2009 by and between Maxygen, Inc. a Delaware corporation, having its principal offices at 515 Galveston Drive Redwood City, CA 94063 (together with its Affiliates, “Maxygen”), Astellas Pharma Inc., a Japanese corporation, having its principal offices at 2-3-11, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan (“Astellas”) and Astellas Bio Inc., a Delaware corporation, having its principal offices at Three Parkway North Deerfield, IL 60015-2548 (“Bio”). Maxygen, Astellas and Bio are together referred to herein as the “Parties.”
MASTER JOINT VENTURE AGREEMENT by and between Maxygen, Inc., a Delaware Corporation, Astellas Phama Inc., a Japanese Corporation, and Astellas Bio Inc., a Delaware Corporation Dated as of June 30, 2009Master Joint Venture Agreement • July 1st, 2009 • Maxygen Inc • Services-commercial physical & biological research • Delaware
This Master Joint Venture Agreement (this “Agreement”) is made and entered into as of this 30th day of June, 2009 by and between Maxygen, Inc. a Delaware corporation, having its principal offices at 515 Galveston Drive Redwood City, CA 94063 (together with its Affiliates, “Maxygen”), Astellas Pharma Inc., a Japanese corporation, having its principal offices at 2-3-11, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan (“Astellas”) and Astellas Bio Inc., a Delaware corporation, having its principal offices at Three Parkway North Deerfield, IL 60015-2548 (“Bio”). Maxygen, Astellas and Bio are together referred to herein as the “Parties.”
